Hellerup, Denmark

Vladislav Soroka

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Vladislav Soroka. Retrieved from https://idiyas.com/inventor/vladislav-soroka-e5xdwx3m

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:

goldMedal1 out of 834,601 
Other
 patents

Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Vladislav Soroka

Introduction

Vladislav Soroka is an accomplished inventor based in Hellerup, Denmark. He has made significant contributions to the field of biotechnology, particularly in the development of compounds that interact with neural cell adhesion molecules.

Latest Patents

Vladislav holds a patent for NCAM binding compounds. This invention provides novel compounds capable of stimulating the proliferation and outgrowth of cells that present the neural cell adhesion molecule (NCAM). Additionally, the patent encompasses pharmaceutical compositions, medicaments, and methods for treating normal, degenerated, and damaged NCAM-presenting cells.

Career Highlights

Throughout his career, Vladislav has focused on advancing medical science through innovative solutions. His work has the potential to impact treatments for various neurological conditions, showcasing his dedication to improving healthcare.

Collaborations

Vladislav has collaborated with notable professionals in his field, including Lars Christian Ronn and Arne Holm. These partnerships have contributed to the development and refinement of his inventions.

Conclusion

Vladislav Soroka's innovative work in developing NCAM binding compounds highlights his significant role in biotechnology. His contributions are paving the way for advancements in medical treatments and therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…